Agilent | A - Операционный доход





Операционный доход Изменить Дата
Abbott USD 2.13B 281M 2026-06
Agilent USD 399M 46M 2026-03
Align Technology USD 191.32M 13.27M 2026-06
Bio Techne USD 75.49M 21.03M 2026-03
Bio-Rad Laboratories USD 72.6M 38.5M 2026-06
Bruker USD 69.6M 59.4M 2026-06
Charles River Laboratories USD 119.89M 9K 2026-06
Danaher USD 1.13B 217M 2026-06
Dentsply International USD 84M 52M 2026-06
Edwards Lifesciences USD 519.5M 4.8M 2026-06
Henry Schein USD 200M 18M 2026-06
Illumina USD 260M 21M 2026-06
Intuitive Surgical USD 977.6M 117.9M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Laboratory Of America USD 456.7M 46.6M 2026-06
Mettler Toledo International USD 287.55M 53.61M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Quest Diagnostics USD 459M 60M 2026-06
Quidel USD -15.3M 16.5M 2026-06
Repligen USD 21.13M 1.15M 2026-06
Revvity USD 126.14M 43.36M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Waters USD -86M 234M 2026-06
Zimmer Biomet Holdings USD 344.7M 50.4M 2026-06